Real‐world adherence and persistence with direct oral anticoagulants in adults with atrial fibrillation
Background Evidence of adherence and persistence patterns in anticoagulation (AC)
therapy comparing treatment‐naïve and non‐naïve patients is lacking. The objective of this …
therapy comparing treatment‐naïve and non‐naïve patients is lacking. The objective of this …
Non-vitamin K antagonist oral anticoagulants: impact of non-adherence and discontinuation
JM Rivera-Caravaca, MA Esteve-Pastor… - Expert Opinion on …, 2017 - Taylor & Francis
ABSTRACT Introduction: Non-Vitamin K Antagonist Oral Anticoagulants (NOACs) are at
least as effective as vitamin K antagonists (VKAs) reducing thromboembolism and mortality …
least as effective as vitamin K antagonists (VKAs) reducing thromboembolism and mortality …
Quality of life with rivaroxaban in patients with non-valvular atrial fibrilation by therapeutic compliance
E Márquez-Contreras, N Martell-Claros… - Quality of Life …, 2017 - Springer
Objective To assess the quality of life (QOL) with rivaroxaban in patients with non-valvular
atrial fibrilation (NVAF) related to therapeutic compliance. Methods Prospective, longitudinal …
atrial fibrilation (NVAF) related to therapeutic compliance. Methods Prospective, longitudinal …
Anticoagulation control in swiss primary care: Time in therapeutic range percentages exceed benchmarks of phase III trials
S Djalali, F Valeri, B Gerber… - Clinical and Applied …, 2017 - journals.sagepub.com
Background: In randomized controlled trials, non-vitamin K antagonist oral anticoagulants
(NOACs) demonstrated noninferiority to vitamin K antagonists (VKAs) in patients who spent …
(NOACs) demonstrated noninferiority to vitamin K antagonists (VKAs) in patients who spent …